News Room
Novo Nordisk A/S

Copenhagen : NOVO B

September 28, 2012 10:05 ET

Novo Nordisk A/S: Novo Nordisk Discontinues Development of Vatreptacog alfa Following Analysis of Phase 3 Results

BAGSVAERD, DENMARK--(Marketwire - Sep 28, 2012) - Company Announcement No 60 2012: http://hugin.info/2013/R/1644628/529831.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE [HUG#1644628]

Contact Information

  • Novo Nordisk A/S
    Novo Alle, DK-2880
    Bagsvaerd, Danmark
    T. Tlf. +45 44 44 88 88
    F. Fax +45 44 44 49 05

News Room